Chairman Charles E. Grassley, right, and ranking member Sen. Ron Wyden are seen before a Senate Finance Committee on drug pricing in America on February 26, 2019. (Tom Williams/CQ Roll Call)
Both the House and the Senate have competing bills aimed at addressing the rising costs of prescription drugs, a legislative priority backed by President Donald Trump.
But what would these various proposals accomplish, and how likely is it they’ll be signed into law?
[jwp-video n=”1″]
Recent Stories
Court challenges mount over Trump’s funding clawback
Schmitt show — Congressional Hits and Misses
Photos of the week | September 25-October 1, 2026
House Democrats grow more bullish about midterms as target list expands
Guns, voting and immigration on deck for Supreme Court
‘Pain in the ass’: Trump again shows annoyance with Paxton after leaked audio